A deep learning integrated radiomics model for identification of coronavirus disease 2019 using computed tomography.

Journal: Scientific reports
Published Date:

Abstract

Since its first outbreak, Coronavirus Disease 2019 (COVID-19) has been rapidly spreading worldwide and caused a global pandemic. Rapid and early detection is essential to contain COVID-19. Here, we first developed a deep learning (DL) integrated radiomics model for end-to-end identification of COVID-19 using CT scans and then validated its clinical feasibility. We retrospectively collected CT images of 386 patients (129 with COVID-19 and 257 with other community-acquired pneumonia) from three medical centers to train and externally validate the developed models. A pre-trained DL algorithm was utilized to automatically segment infected lesions (ROIs) on CT images which were used for feature extraction. Five feature selection methods and four machine learning algorithms were utilized to develop radiomics models. Trained with features selected by L1 regularized logistic regression, classifier multi-layer perceptron (MLP) demonstrated the optimal performance with AUC of 0.922 (95% CI 0.856-0.988) and 0.959 (95% CI 0.910-1.000), the same sensitivity of 0.879, and specificity of 0.900 and 0.887 on internal and external testing datasets, which was equivalent to the senior radiologist in a reader study. Additionally, diagnostic time of DL-MLP was more efficient than radiologists (38 s vs 5.15 min). With an adequate performance for identifying COVID-19, DL-MLP may help in screening of suspected cases.

Authors

  • Xiaoguo Zhang
    School of Instrument Science and Engineering, Southeast University, Nanjing 210096, China.
  • Dawei Wang
    Institute of Advanced Research, Infervision Medical Technology Co., Ltd, Beijing, China.
  • Jiang Shao
    Department of Radiology, Jinan Infectious Disease Hospital, Shandong University, 22029# Jing-Shi Road, Jinan, 250021, People's Republic of China.
  • Song Tian
    Infervision, Beijing, China.
  • Weixiong Tan
    Beijing Infervision Technology Co. Ltd., Beijing, 100025, China.
  • Yan Ma
    Medical School of Chinese PLA, 100853 Beijing, China.
  • Qingnan Xu
    Department of Respiratory Medicine, Jinan Infectious Disease Hospital, Shandong University, 22029# Jing-Shi Road, Jinan, 250021, Shandong, People's Republic of China.
  • Xiaoman Ma
    Department of Respiratory Medicine, Jinan Infectious Disease Hospital, Shandong University, 22029# Jing-Shi Road, Jinan, 250021, Shandong, People's Republic of China.
  • Dasheng Li
    Department of Radiology, Beijing Haidian Section of Peking University Third Hospital (Beijing Haidian Hospital), 29# Zhongguancun Road, Haidian District, Bejing, 100080, People's Republic of China.
  • Jun Chai
    Department of Radiology, Inner Mongolia Autonomous Region People's Hospital, 20# Zhaowuda Road, Hohhot, 010017, People's Republic of China.
  • Dingjun Wang
    Department of Radiology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, 365# Renmin East Road, Wucheng District, Jinhua, 321000, People's Republic of China.
  • Wenwen Liu
    School of Computer and Information Technology, Beijing Jiaotong University, Beijing, 100044, China.
  • Lingbo Lin
    Department of Radiology, Jinan Infectious Disease Hospital, Shandong University, 22029# Jing-Shi Road, Jinan, 250021, People's Republic of China.
  • Jiangfen Wu
    Department of Biomedical Engineering, College of Automation, Nanjing University of Aeronautics and Astronautics, No. 29, Yudao St., Qinhuai District, Nanjing, 210016, Jiangsu Province, China, wjfyunzhu@163.com.
  • Chen Xia
    Institute of Advanced Research, Infervision Medical Technology Co., Ltd, Beijing, China.
  • Zhongfa Zhang
    Department of Respiratory Medicine, Jinan Infectious Disease Hospital, Shandong University, 22029# Jing-Shi Road, Jinan, 250021, Shandong, People's Republic of China. zhzflab@163.com.